Position in ENTA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$258,927
+$98,357 QoQ
Shares Held
20,501
+101.3% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FOX RUN MANAGEMENT, L.L.C. holds $18,757,602 across 55 Biotechnology names. ENTA ranks #29 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
18,715 | $897,758 | |
| 2 | NUVL |
Nuvalent, Inc.
|
8,173 | $837,323 | |
| 3 | RARE |
Ultragenyx Pharmaceutical Inc.
|
37,136 | $777,999 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
10,778 | $696,582 | |
| 5 | SLNO |
Soleno Therapeutics Inc
|
19,934 | $667,390 | |
| 6 | ADMA |
Adma Biologics, Inc.
|
73,991 | $666,658 | |
| 7 | ONC |
BeOne Medicines Ltd.
|
2,136 | $634,327 | |
| 8 | ELVN |
Enliven Therapeutics, Inc.
|
15,573 | $610,461 |
All Filings in ENTA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $258,927 | 20,501 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $160,570 | 10,182 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||